ESLAW Estrella Immunopharma, Inc. - Warrant
$0.07
가격 · 8월 11, 2026
기준 재무 정보 8월 13, 2026
ESLAW 주식 스냅샷 가격, 시가총액, P/E, EPS, ROE, 부채/자본, 52주 범위
가격
$0.07
시가총액
—
P/E (TTM)
—
EPS (TTM)
$-0.35
매출 (TTM)
—
배당 수익률
—
ROE
158.7%
부채/자본
—
52주 범위
$0 – $0
ESLAW 주가 차트 기술 지표가 포함된 일일 OHLCV — 팬, 확대/축소 및 보기 사용자 정의
Configure
10년 성과 매출, 순이익, 마진 및 EPS 추세
매출 및 순이익
—
EPS
$-0.35
2023-06-30
→
2025-12-31
잉여현금흐름
—
마진
—
가치 평가 P/E, P/S, P/B, EV/EBITDA 비율 — 주식이 비싼가요, 싼가요?
지표
5년 추세
ESLAW
동종업계 중앙값
수익성 총, 영업 및 순이익률; ROE, ROA, ROIC
지표
5년 추세
ESLAW
동종업계 중앙값
ROA
-413.6%
—
ROE
158.7%
—
ROIC
126.0%
—
재무 건전성 부채, 유동성, 지급능력 — 대차대조표 건전성
지표
5년 추세
ESLAW
동종업계 중앙값
Current Ratio (유동비율)
0.1
—
Quick Ratio (당좌 비율)
0.1
—
성장 매출, EPS 및 순이익 성장률: YoY, 3년 CAGR, 5년 CAGR
지표
5년 추세
ESLAW
동종업계 중앙값
자본 효율성 자산 회전율, 재고 회전율, 매출채권 회전율
지표
5년 추세
ESLAW
동종업계 중앙값
전체 기본 지표 연도별 모든 지표 — 손익계산서, 대차대조표, 현금흐름
손익계산서 13
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $10M | · | $10M | · | · | |
| SG&A Expense | $3M | · | $663.2K | · | · | |
| Operating Expenses | $13M | · | $11M | · | · | |
| Operating Income | $-13M | · | $-11M | $-2M | $-249.1K | |
| Interest Income | · | · | · | $654.1K | $1.4K | |
| Pretax Income | $-13M | · | $-11M | $-915.5K | $-247.7K | |
| Income Tax | $838 | · | · | $80.6K | $0 | |
| Net Income | $-13M | · | $-11M | $-996.1K | $-247.7K | |
| EPS (Basic) | $-0.35 | · | $-36.35 | · | · | |
| EPS (Diluted) | $-0.35 | · | $-36.35 | · | · | |
| Shares (Basic) | 36,820,810 | · | 305,748 | · | 1,179,328 | |
| Shares (Diluted) | 36,820,810 | · | 305,748 | · | 1,179,328 | |
| EBITDA | $-13M | · | · | $-2M | $-249.1K |
대차대조표 18
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $1M | $916.9K | $2M | $40.8K | $478.9K | |
| Receivables | · | · | $273.1K | · | · | |
| Prepaid Expense | $292.7K | $723.9K | · | $11.6K | $137.2K | |
| Current Assets | $2M | $2M | $3M | $52.4K | $616.0K | |
| Total Assets | $3M | $3M | $3M | $10M | $46M | |
| Accounts Payable | · | · | · | $329.2K | $3.0K | |
| Accrued Liabilities | · | · | $116.5K | · | · | |
| Current Liabilities | $14M | $3M | $10M | $1M | $73.2K | |
| Deferred Tax | · | · | · | $29.5K | · | |
| Other Non-current Liabilities | · | · | $12.7K | · | · | |
| Total Liabilities | $14M | $3M | $10M | $3M | $2M | |
| Common Stock | $3.8K | $3.7K | $98 | $142 | $142 | |
| Paid-in Capital | $27M | $25M | $445.9K | · | · | |
| Retained Earnings | $-37M | $-24M | $-12M | $-2M | $-1M | |
| Treasury Stock | $598.4K | $568.9K | · | · | · | |
| Stockholders' Equity | $-10M | $143.7K | $-12M | $-6M | $-1M | |
| Liabilities + Equity | $3M | $3M | $3M | $10M | $46M | |
| Shares Outstanding | · | 36,193,891 | 978,243 | 1,419,700 | 1,419,700 |
현금 흐름 9
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Stock-based Comp | $619.0K | · | $409.6K | · | · | |
| Deferred Tax | · | · | · | $29.5K | · | |
| Operating Cash Flow | $-2M | · | $-1M | $-1M | $-316.2K | |
| Investing Cash Flow | · | · | $-273.1K | $36M | $-45M | |
| Stock Issued | $2M | · | · | · | $25.0K | |
| Net Stock Activity | $2M | · | · | · | $25.0K | |
| Financing Cash Flow | $2M | · | · | $-36M | $46M | |
| Net Change in Cash | · | · | · | $-438.1K | $478.9K | |
| Taxes Paid | $913 | · | · | · | · |
수익성 3
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -413.6% | · | · | -3.6% | -1.1% | |
| ROE | 158.7% | · | · | 32.8% | 26.4% | |
| ROIC | 126.0% | · | · | 75.7% | 24.8% |
유동성 및 지급능력 2
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 0.1 | · | · | 0.0 | 8.4 | |
| Quick Ratio | 0.1 | · | · | 0.0 | 6.5 |
가치 평가 (TTM) 1
| 지표 | 추세 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-13M | · | · | $-996.1K | $-247.7K |
손익계산서 14
| 지표 | 추세 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $1M | $25.4K | $4M | $5M | $1M | $4M | $25.0K | $75.5K | $483.5K | $3M | $3M | $3M | $3M | · | · | |
| SG&A Expense | $684.0K | $587.8K | $648.5K | $883.7K | $694.1K | $424.4K | $444.5K | $945.2K | $1M | $116.8K | $117.7K | $148.4K | $280.3K | · | · | |
| Operating Expenses | $2M | $613.2K | $5M | $6M | $2M | $4M | $469.5K | $1M | $2M | $3M | $3M | $3M | $3M | · | · | |
| Operating Income | $-2M | $-613.2K | $-5M | $-6M | $-2M | $-4M | $-469.5K | $-1M | $-2M | $-3M | $-3M | $-3M | $-3M | $-423.8K | $-144.9K | |
| Interest Income | · | · | · | · | · | · | · | · | · | $114.3K | $105.8K | $381.9K | $204.3K | $64.2K | $3.7K | |
| Other Non-op | $-222.1K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Pretax Income | $-2M | $-613.2K | $-5M | $-6M | $-2M | $-4M | $-469.5K | · | $-2M | $-54.9K | · | · | · | $-359.6K | $-141.3K | |
| Income Tax | · | $-25 | · | $850 | $13 | $1.6K | · | · | · | $21.1K | $19.5K | $80.6K | $0 | · | $0 | |
| Net Income | $-2M | $-613.2K | $-5M | $-6M | $-2M | $-4M | $-469.5K | $-1M | $-2M | $-3M | $-3M | $-3M | $-3M | $-359.6K | $-141.3K | |
| EPS (Basic) | $-0.05 | $-0.01 | $-0.13 | $-0.15 | $-0.06 | $-0.11 | $-0.01 | $-0.03 | $-1.78 | $22.44 | $-8.13 | $-16.33 | $-34.33 | $-0.06 | $-0.02 | |
| EPS (Diluted) | $-0.05 | $-0.01 | $-0.13 | $-0.15 | $-0.06 | $-0.11 | $-0.01 | $-0.03 | $-1.78 | $22.44 | $-8.13 | $-16.33 | $-34.33 | $-0.06 | $-0.02 | |
| Shares (Basic) | 42,997,733 | -72,629,096 | 37,096,024 | 36,165,589 | 36,188,293 | 36,376,738 | 35,519,192 | 35,201,232 | 1,052,656 | -284,326 | 337,275 | 168,758 | 84,041 | 1,419,700 | 1,419,700 | |
| Shares (Diluted) | 42,997,733 | -72,629,096 | 37,096,024 | 36,165,589 | 36,188,293 | 36,376,738 | 35,519,192 | 35,201,232 | 1,052,656 | -284,326 | 337,275 | 168,758 | 84,041 | 1,419,700 | 1,419,700 | |
| EBITDA | $-2M | · | $-5M | $-6M | $-2M | · | $-469.5K | $-1M | $-2M | $-169.2K | $-149.7K | · | $-549.2K | $-423.8K | $-144.9K |
대차대조표 17
| 지표 | 추세 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $100.0K | $1M | $2M | $1M | $421.5K | $4M | $5M | $9M | $22M | $2M | $29.4K | $40.8K | $73.8K | $88.3K | $321.7K | |
| Prepaid Expense | $178.0K | $292.7K | $396.9K | $163.9K | $522.8K | $288.8K | $406.1K | $401.2K | $138.8K | $94.7K | $52.5K | $11.6K | $87.0K | $40.5K | $106.4K | |
| Current Assets | $2M | $2M | $2M | $1M | $944.3K | $4M | $9M | $9M | · | $3M | $81.9K | $52.4K | $160.8K | $128.8K | $428.1K | |
| Total Assets | $2M | $3M | $4M | $3M | $2M | $4M | $9M | $9M | $27M | $3M | $10M | $10M | $46M | $45M | $46M | |
| Accounts Payable | · | · | · | · | · | · | · | · | · | $437.8K | $375.0K | $329.2K | $206.5K | $106.4K | $6.0K | |
| Accrued Liabilities | · | · | · | · | · | · | $166.9K | · | · | · | · | · | · | · | · | |
| Current Liabilities | $9M | $14M | $13M | $9M | $4M | $180.7K | $138.5K | $398.7K | $17M | $10M | $1M | $1M | $735.8K | $154.6K | $30.2K | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $8.4K | $7.8K | $29.5K | · | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | · | · | · | $12.7K | · | · | · | · | · | |
| Total Liabilities | $9M | $14M | $13M | $9M | $4M | $180.7K | $138.5K | $398.7K | $17M | $10M | $3M | $3M | $2M | $2M | $2M | |
| Common Stock | $4.4K | $3.8K | $3.8K | $3.8K | $3.7K | $3.7K | $3.7K | $3.5K | $3.5K | $98 | $142 | $142 | $142 | $142 | $142 | |
| Paid-in Capital | $35M | $27M | $27M | $26M | $25M | · | $24M | $24M | $24M | · | · | · | · | · | · | |
| Retained Earnings | $-42M | $-37M | $-36M | $-32M | $-26M | $-20M | $-16M | $-15M | $-14M | $-12M | $-3M | $-2M | $-2M | $-2M | $-1M | |
| Treasury Stock | $598.4K | $598.4K | $598.4K | $598.4K | $598.4K | $354.4K | $84.1K | · | · | · | · | · | · | · | · | |
| Stockholders' Equity | $-7M | $-10M | $-10M | $-6M | $-2M | $4M | $8M | $9M | $10M | $-12M | $-3M | $-2M | $-2M | $-2M | $-1M | |
| Liabilities + Equity | $2M | $3M | $4M | $3M | $2M | $4M | $9M | $9M | $27M | $3M | $10M | $10M | $46M | $45M | $46M | |
| Shares Outstanding | · | · | 37,765,589 | 37,065,589 | 36,165,589 | 36,610,870 | 36,535,980 | 35,201,232 | 35,201,232 | 978,243 | 1,419,700 | 1,419,700 | 1,419,700 | 1,419,700 | 1,419,700 |
현금 흐름 8
| 지표 | 추세 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $145.3K | $148.4K | $152.4K | $159.1K | $159.1K | · | · | · | $1M | $102.4K | $102.4K | $102.4K | $102.4K | · | · | |
| Deferred Tax | · | · | · | · | · | · | · | · | · | $598 | $-21.7K | · | · | · | · | |
| Operating Cash Flow | $-2M | $-177.5K | $-727.3K | $1M | $-466.0K | $-4M | $-4M | $-11M | $-275.2K | $-43.2K | $-84.5K | $-108.2K | $-1M | $-233.4K | $-157.1K | |
| Investing Cash Flow | · | · | · | · | · | $0 | $0 | $5M | $-112.3K | $-136.5K | $-235.7K | · | · | · | · | |
| Stock Issued | $0 | $0 | $1M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $4 | $-64.8K | $1M | $1M | $-29.5K | $-20M | $-84.1K | $-7M | $20M | $196.5K | $186.5K | $-36M | · | · | · | |
| Net Change in Cash | · | · | · | · | · | · | · | · | · | $5.3K | $-11.4K | $-33.0K | $-14.5K | $-233.4K | $-157.1K | |
| Taxes Paid | · | $0 | $0 | $900 | $13 | $0 | · | · | · | · | · | · | · | · | · |
수익성 3
| 지표 | 추세 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -96.0% | · | -79.0% | -89.2% | -68.1% | · | -1.7% | -10.5% | -10.1% | -0.27% | -0.23% | · | -0.75% | -1.6% | -0.62% | |
| ROE | 34.1% | · | 715.8% | -375.4% | 388.0% | · | -14.4% | -32.8% | -49.6% | 3.5% | 3.5% | · | 24.2% | 47.7% | 24.6% | |
| ROIC | · | · | · | 91.0% | 114.9% | · | · | · | · | 8.3% | 8.5% | · | 27.7% | 28.1% | 12.6% |
유동성 및 지급능력 2
| 지표 | 추세 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 62.3 | 23.7 | · | 0.1 | 0.1 | · | 0.2 | 0.8 | 14.2 | |
| Quick Ratio | 0.0 | · | 0.1 | 0.1 | 0.1 | · | 34.1 | 22.7 | 1.3 | 0.0 | 0.0 | · | 0.1 | 0.6 | 10.7 |
가치 평가 (TTM) 3
| 지표 | 추세 | Q2 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-15M | · | $-16M | $-14M | $-13M | · | · | $-3M | · | $-11M | · | · | · | $-611.9K | $-253.2K | |
| P/E | -0.3 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -292.1% | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
재무제표 손익계산서, 대차대조표, 현금흐름 — 연간, 지난 5년
손익계산서
| 2025-12-31 | 2024-12-31 | 2024-06-30 | 2023-06-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| 순이익 | $-13M | — | $-7M | $-11M | $-996.1K |
| 희석 EPS | $-0.35 | — | $-0.27 | $-36.35 | — |
대차대조표
| 2025-12-31 | 2024-12-31 | 2024-06-30 | 2023-06-30 | 2022-12-31 | |
|---|---|---|---|---|---|
| 유동비율 | 0.1 | — | — | — | 0.0 |
| 당좌 비율 | 0.1 | — | — | — | 0.0 |
나의 지표 나만의 관심 목록 — 전체 기본 재무제표에서 선택한 항목
📊
중요한 지표를 선택하세요 — 위 전체 기본 재무제표의 아무 행 옆에 있는 ➕를 클릭하세요.
선택 항목이 저장되어 모든 티커에서 유지됩니다.
기관 투자자 (13F) 11개의 제출자 · $256K 전체 · 기준일 2026년 6월 30일
분기별 SEC 양식 13F에서 이 주식을 보유하고 있다고 보고하는 기관. 롱 포지션만 해당하며, 단일 제출자는 별도의 옵션 레그에 대해 두 번 나타날 수 있습니다. 대규모 상쇄 풋/콜 포지션은 일반적으로 방향성에 대한 확신보다는 시장 조성 또는 헤지된 재고를 반영합니다.
기관 활동 — Q2 2026 대 이전 분기
| 신규 포지션 | 청산 포지션 | 증가함 | 감소 | 순주식 변동 |
|---|---|---|---|---|
| 0 (0 이전 분기 대비) | 0 (-1 이전 분기 대비) | 0 (-1 이전 분기 대비) | 0 (-2 이전 분기 대비) | -62K |
Q1 2026 대비 비교. SEC 양식 13F 제출은 분기 말로부터 45일 이내에 마감되며, 지연 제출자를 위한 짧은 유예 기간이 추가됩니다. 해당 기간 내에 있는 분기는 가장 최근에 완전히 보고된 쌍을 선호하여 건너뜁니다.
| 기관 | 가치 | 주식 | % 추적된 13F 중 | 유형 |
|---|---|---|---|---|
| BOOTHBAY FUND MANAGEMENT, LLC | $197,495 | 189,899 | 77.09% | 주식 |
| Robertson Stephens Wealth Management, LLC | $12,480 | 12,000 | 4.87% | 주식 |
| D. E. Shaw & Co., Inc. | $12,460 | 87,500 | 4.86% | 주식 |
| ATW SPAC MANAGEMENT LLC | $9,485 | 183,099 | 3.70% | 주식 |
| Yakira Capital Management, Inc. | $6,017 | 46,285 | 2.35% | 주식 |
| WHITEBOX ADVISORS LLC | $5,498 | 42,293 | 2.15% | 주식 |
| Clear Street Group Inc. | $4,431 | 34,082 | 1.73% | 주식 |
| CITIGROUP INC | $3,900 | 30,000 | 1.52% | 콜 옵션 |
| TORONTO DOMINION BANK | $2,813 | 21,635 | 1.10% | 주식 |
| CLEAR STREET LLC | $1,614 | 33,982 | 0.63% | 주식 |
| SkyView Investment Advisors, LLC | $5 | 62,500 | 0.00% | 주식 |